MARIA ORTIZ: Open Payments
NPI 1790236560 · WESTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,426 in 16 payments from 10 companies in 2025. Trend: 2023 $344 · 2024 $457 · 2025 $1,426
Food & beverage: $1,426
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $461 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $197 |
| ABBVIE INC. | 2 | $139 |
| Optinose US, Inc. | 1 | $127 |
| Neurocrine BioSciences, Inc. | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $121 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $120 |
| Novo Nordisk Inc | 1 | $98 |
| Nalu Medical, Inc. | 1 | $23 |
| SCILEX PHARMACEUTICALS INC. | 1 | $15 |
Products named: UPLIZNA, Xhance, Kerendia, INGREZZA, EVENITY, UBRELVY, JARDIANCE, XIFAXAN.
Industry payments across FL — which companies pay providers there.
